RAINIER

Currently Enrolling

See all Clinical Trials

The RAINIER Study: RAINIER is a phase 3 registrational, randomized, placebo-controlled study of povetacicept in adults with IgA Nephropathy (IgAN). The drug is administered once every 4 weeks as a subcutaneous injection.

Learn More

Considering a Clinical Trial?

Clinical Trials Handout

The IgA Nephropathy Foundation is working with the partners below to provide our patients access to breakthrough clinical trials. Patient participation is the key to finding treatment and the ultimate cure for IgA Nephropathy. Read more about each trial below to see if you are eligible.

Considering a Clinical Trial? View All Clinical Trials Download Handout Here